Rumors circulating late last month proved true with Baxter (NYSE:BAX) this week announced that it had signed a $4 billion (26.5 billion SEK) merger agreement with Swedish dialysis giant Gambro.
Mergers & Acquisitions
Merit Medical to buy catheter maker Medigroup for an undisclosed amount
Merit Medical Systems (NSDQ:MMSI) agreed to acquire Medigroup, a peritoneal dialysis catheters manufacturer based in Illinois, for an undisclosed amount.
Report: Blackstone leads race for Allscripts | Wall Street Beat
Blackstone Group is said to be leading the bidding war for electronic medical records company Allscripts (NSDQ:MDRX) but the 2 sides are far from agreeing on a price, according to Reuters.
Citing 3 "people familiar with the matter," the news agency said a deal is "highly uncertain."
Volcano has big plans for new $36M Crux Biomedical acquisition
Wright Medical begins buying up BioMimetic shares
Feds charge ex-baseballer DeCinces with insider trading in Abbott/AMO deal
Smith & Nephew’s $782M Healthpoint buyout raises eyebrows
Healthcare giant Smith & Nephew (FTSE:SN, NYSE:SNN) today announced a $782 million cash bid to acquire wound care products maker Healthpoint Biotherapeutics, a move that sparked mixed reactions from Wall Street.
Covidien updates on pharma spinout
With strong fiscal 2012 numbers under its belt, Covidien (NYSE:COV) updated investors today on its expected financials after it spins out its pharmaceuticals business next year.
The Mansfield, Mass.-based medical device company said late last year that it planned to ditch the no-or-low-growth pharma unit, which will become a stand-alone operation.
Merit Medical to pay $167M for GE Healthcare’s Thomas Medical OEM vascular access biz
Merit Medical Systems (NSDQ:MMSI) agreed to pony up some $167 million for GE Healthcare‘s (NYSE:GE) Thomas Medical Products business, which makes an OEM maker of catheters used for vascular access.
Volcano acquires cardiovascular imaging company Sync-Rx for $17.3M
Medical device maker Volcano (NSDQ:VOLC) signed a definitive agreement to purchase all outstanding shares of Israeli imaging software maker Sync-Rx for a total price of $17.3 million.
Sync-Rx, which develops programs that optimize imaging during transcatheter cardiovascular interventions, will continue to operate in Israel and is expected to retain nearly all of its workers, according to a regulatory filing.
Survey: Heart docs say Edwards on track for solid heart valve growth | Wall Street Beat
Edwards Lifesciences (NYSE:EW) is on track for solid growth in the transcatheter aortic valve implant market, according to a survey of cardiologists conducted by Leerink Swann analysts.